Brain and psychological determinants of placebo pill response in chronic pain patients
PainSci notes on Vachon-Presseau 2018:
This trial claims to have found evidence of psychological and neurological traits that predict the potency and duration of placebo response. It’s garbage, a terrible study and a terrible paper. It seems to bizarrely prides itself on using a no-treatment group when this is clearly a poor choice, highly subject to a “frustrebo” effect. It is far too small a study, to underpowered, to actually detect a correlation between such squishy things as psychological traits and placebo response. The authors exhibit an egregious placebo-hype bias in their public statements and in the paper itself, and their methodology has a huge amount of “wiggle room” for p-hacking and rampant methodological flexibility. And there’s more.
Dr. James Coyne criticized the paper thoroughly and harshly for ScienceBasedMedicine.org. See: Debunking the magical power of the placebo effect for chronic pain (yet again).
original abstract †Abstracts here may not perfectly match originals, for a variety of technical and practical reasons. Some abstacts are truncated for my purposes here, if they are particularly long-winded and unhelpful. I occasionally add clarifying notes. And I make some minor corrections.
The placebo response is universally observed in clinical trials of pain treatments, yet the individual characteristics rendering a patient a 'placebo responder' remain unclear. Here, in chronic back pain patients, we demonstrate using MRI and fMRI that the response to placebo 'analgesic' pills depends on brain structure and function. Subcortical limbic volume asymmetry, sensorimotor cortical thickness, and functional coupling of prefrontal regions, anterior cingulate, and periaqueductal gray were predictive of response. These neural traits were present before exposure to the pill and most remained stable across treatment and washout periods. Further, psychological traits, including interoceptive awareness and openness, were also predictive of the magnitude of response. These results shed light on psychological, neuroanatomical, and neurophysiological principles determining placebo response in RCTs in chronic pain patients, and they suggest that the long-term beneficial effects of placebo, as observed in clinical settings, are partially predictable.
Specifically regarding Vachon-Presseau 2018:
- “Debunking the magical power of the placebo effect for chronic pain (yet again),” James Coyne, Sciencebasedmedicine.org.
This page is part of the PainScience BIBLIOGRAPHY, which contains plain language summaries of thousands of scientific papers & others sources. It’s like a highly specialized blog. A few highlights:
- Inciting events associated with lumbar disc herniation. Suri 2010 Spine J.
- Prediction of an extruded fragment in lumbar disc patients from clinical presentations. Pople 1994 Spine (Phila Pa 1976).
- Characteristics of patients with low back and leg pain seeking treatment in primary care: baseline results from the ATLAS cohort study. Konstantinou 2015 BMC Musculoskelet Disord.
- Effectiveness and cost-effectiveness of universal school-based mindfulness training compared with normal school provision in reducing risk of mental health problems and promoting well-being in adolescence: the MYRIAD cluster randomised controlled trial. Kuyken 2022 Evid Based Ment Health.
- Is there a relationship between throbbing pain and arterial pulsations? Mirza 2012 J Neurosci.